Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes — the upper arm is one of three licensed injection sites for Wegovy. Alongside the abdomen and thigh, the outer area of your upper arm (the deltoid region) is specifically included in the Wegovy Summary of Product Characteristics as an approved subcutaneous site. You should rotate between sites each week to keep the skin healthy and avoid tissue changes over time. Like all GLP-1 receptor agonists, Wegovy is a prescription-only medicine: a prescriber assesses suitability before any treatment begins, and your technique should be guided by the instructions in your Patient Information Leaflet.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The correct zone is the outer, middle portion of your upper arm, sometimes described as the lateral deltoid area. This is the patch of softer tissue about halfway between your shoulder and elbow on the outside of the arm. The aim is subcutaneous injection: the needle goes into the layer of fat just under the skin, not into muscle. Muscle injections are more painful, absorb the medicine differently, and are not the intended route.
A useful check: you should be able to gently pinch a fold of skin at the chosen spot. If there is very little subcutaneous tissue, the upper arm may not be practical for self-injection at that point in your treatment. The Wegovy arm injection site matters because consistent accuracy reduces the chance of injection-site reactions.
Avoid areas with visible veins or recent injection marks. Avoid tattooed skin where possible. If you have recently had blood taken or a vaccine in that arm, wait until any soreness has passed before using that site. Full detail on distances and pinch technique is set out in the Patient Information Leaflet that accompanies your pen, and if you are wondering whether Wegovy is a single-use pen, the leaflet's illustrated instructions are the definitive reference.
This is a question our prescribers hear most weeks, because the answer is nuanced. Many people can self-inject into the upper arm by steadying the pen against a firm surface, holding the arm relaxed at the side, and pressing the pen flat against the outer tissue. The Wegovy pen has a fixed-needle design, so there is no separate needle to attach, and the trigger mechanism makes one-handed use more manageable than it might seem.
That said, some people find the angle awkward, particularly at lower body weights where pinchable tissue in the arm is limited. If upper-arm self-injection feels unstable, two practical alternatives work just as well: ask a family member or carer to administer the injection there, or simply use the abdomen or thigh that week. Rotating across all three sites over several weeks is actually preferable to using one site exclusively, so shifting between the arm, thigh, and abdomen serves both convenience and skin health.
Your prescriber or a nurse can demonstrate the technique during a consultation. If you are uncertain, the NHS patient-level guidance on semaglutide (the active ingredient in Wegovy) covers practical injection guidance and is worth reading alongside your leaflet.
Not in a clinically meaningful way for most people. Studies across Wegovy's development programme found consistent absorption whether the injection was given in the abdomen, thigh, or upper arm. The STEP 1 trial, which showed an average body-weight reduction of around 15% over 68 weeks, did not restrict participants to a single injection site. So you are not sacrificing efficacy by choosing the arm on a given week.
Where site choice can matter is in the rate of absorption early on. The abdomen tends to have the fastest subcutaneous absorption, the thigh slightly slower, the arm sitting broadly in the middle. These differences are small and unlikely to be noticeable day-to-day, but they are one reason the prescribing guidance recommends rotation rather than locking onto one site. Wegovy's full prescribing profile includes more background on how the medicine is used in practice.
One practical point worth knowing: if you are using alcohol swabs to clean the skin before injecting (a sensible habit), allow the area to dry completely before pressing the pen in. Wet skin can sting. A pack of alcohol swabs is a tidy addition to your weekly routine.
Redness, mild swelling or a small raised area at the injection point is common and usually settles within a few hours. These local reactions are the body responding to the subcutaneous placement rather than a sign of a problem with the medicine. Rotating your site each week keeps any one area from accumulating repeated needle trauma, which matters because repeated injections to the same spot can eventually cause lipohypertrophy, firm, lumpy patches of fatty tissue that can affect absorption.
More significant reactions are uncommon but worth knowing: a hard, warm lump that persists beyond a day or two, spreading redness, or signs of skin infection should be reviewed by a clinician. Widespread itching or urticaria after an injection can indicate an allergic response and warrants prompt medical attention. The MHRA's Yellow Card scheme is open to patients who want to report any suspected side effect, including injection-site reactions, your report genuinely helps regulators track patterns across the population.
If you have questions about your current Wegovy treatment, including how to approach an arm injection with confidence, our aftercare team is available seven days a week. For those yet to start and still wondering whether you can inject Wegovy in your arm, a free consultation with one of our prescribers is the place to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.